E34.321 - Primary insulin-like growth factor-1 (IGF-1) deficiency
- Applicable to Primary insulin-like growth factor-1 (IGF-1) deficiency
- The 2025 edition of ICD10-CM E34.321 became effective on October 1, 2024.
- This is the American ICD10-CM version of E34.321 - other international versions of ICD10 E34.321 may differ.
- E34.321 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Acid-labile subunit gene (IGFALS) defect
- Growth hormone gene 1 (GH1) defect with growth hormone neutralizing antibodies
- Growth hormone insensitivity syndrome (GHIS)
- Insulin-like growth factor 1 gene (IGF1) defect
- Laron type short stature
- Severe primary insulin-like growth factor-1 deficiency (SPIGFD)
- Signal transducer and activator of transcription 5B gene (STAT5b) defect
Billable/Specific Code
The following codes above E34.321 contain annotation back-references that may be applicable to E34.321:
- Chapter: E00-E89 - Endocrine, nutritional and metabolic diseases
- Section: E20-E35 - Disorders of other endocrine glands
- Category: E34 - Other endocrine disorders
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com